Omega Healthcare Investors, Inc. (NYSE:OHI) Receives Average Rating of “Hold” from Analysts

Shares of Omega Healthcare Investors, Inc. (NYSE:OHI) have been assigned an average rating of “Hold” from the twelve ratings firms that are presently covering the firm, MarketBeat reports. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $40.00.

OHI has been the subject of several recent analyst reports. Wells Fargo & Company reiterated an “overweight” rating and set a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. BNP Paribas raised Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective for the company in a research report on Thursday, October 31st. Royal Bank of Canada increased their target price on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research note on Monday, November 11th. BMO Capital Markets increased their target price on Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research note on Monday, October 7th. Finally, Truist Financial increased their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research note on Wednesday, September 4th.

Insider Activity

In related news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. This represents a 10.96 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company’s stock.

Hedge Funds Weigh In On Omega Healthcare Investors

Several institutional investors and hedge funds have recently made changes to their positions in OHI. Assetmark Inc. lifted its stake in Omega Healthcare Investors by 1.7% during the third quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust’s stock worth $48,492,000 after purchasing an additional 19,542 shares during the last quarter. Daiwa Securities Group Inc. lifted its stake in Omega Healthcare Investors by 317.7% during the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock worth $160,739,000 after purchasing an additional 3,003,845 shares during the last quarter. Caxton Associates LP bought a new stake in Omega Healthcare Investors during the second quarter worth $1,652,000. Van ECK Associates Corp lifted its stake in Omega Healthcare Investors by 15.4% during the third quarter. Van ECK Associates Corp now owns 100,145 shares of the real estate investment trust’s stock worth $4,167,000 after purchasing an additional 13,367 shares during the last quarter. Finally, Citigroup Inc. lifted its stake in Omega Healthcare Investors by 20.1% during the third quarter. Citigroup Inc. now owns 351,529 shares of the real estate investment trust’s stock worth $14,307,000 after purchasing an additional 58,950 shares during the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Performance

Shares of NYSE OHI opened at $39.54 on Wednesday. The business’s 50-day moving average price is $40.56 and its two-hundred day moving average price is $37.53. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. Omega Healthcare Investors has a one year low of $27.53 and a one year high of $44.42. The company has a market capitalization of $10.67 billion, a P/E ratio of 29.07, a price-to-earnings-growth ratio of 1.24 and a beta of 0.98.

Omega Healthcare Investors Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were issued a $0.67 dividend. The ex-dividend date was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.78%. Omega Healthcare Investors’s dividend payout ratio (DPR) is 197.06%.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.